Case Study: Powering Long-Term Adherence For A PCSK9 Inhibitor With Predictive Patient Support

PCSK9 inhibitors provide vital cardiovascular protection when statins fail, but patient adherence is challenging. High abandonment rates, low refill persistence, and costly drop-offs impact outcomes and commercial success in chronic care.

This case study shows how a leading pharmaceutical brand partnered with MedAdvisor Solutions to launch a precision-targeted adherence program across 25,900+ pharmacies, achieving results:

• 15.5% rise in injections per patient, adding 22.5 therapy days
• 26% higher first-fill pickup rates with prevention messaging
• 13.6% increase in average refills over six months

Learn how predictive intelligence and pharmacy support improve adherence.